Copyright
©2011 Baishideng Publishing Group Co.
World J Gastroenterol. May 21, 2011; 17(19): 2450-2453
Published online May 21, 2011. doi: 10.3748/wjg.v17.i19.2450
Published online May 21, 2011. doi: 10.3748/wjg.v17.i19.2450
Figure 1 Patient 4 - arterial phase computed tomography scans.
A: Pre-sorafenib, the 25-mm lesion in segment VIII was biopsied, and measured > 100 HU. B: Partial response, tumor necrosis and intra-lesional HU of 40-70 after 4 mo on sorafenib. C: After 40 mo on sorafenib, the necrotic area measured < 40 HU intra-lesionally, and was disease-free at histological examination. The arrows show the liver lesion.
- Citation: Abbadessa G, Rimassa L, Pressiani T, Carrillo-Infante C, Cucchi E, Santoro A. Optimized management of advanced hepatocellular carcinoma: Four long-lasting responses to sorafenib. World J Gastroenterol 2011; 17(19): 2450-2453
- URL: https://www.wjgnet.com/1007-9327/full/v17/i19/2450.htm
- DOI: https://dx.doi.org/10.3748/wjg.v17.i19.2450